EP1711490A4 - Neuer p-glycoproteininhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält - Google Patents

Neuer p-glycoproteininhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält

Info

Publication number: EP1711490A4
Authority: EP; European Patent Office
Prior art keywords: novel; preparation; pharmaceutical composition; same; glycoprotein inhibitor
Prior art date: 2003-10-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP04774781A

Other languages

English (en)

French (fr)

Other versions

EP1711490A1 (de

Inventor

Mi Young Cha

Keuk Chan Bang

Young Gil Ahn

Maeng Sup Kim

Gwan Sun Lee

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hanmi Pharmaceutical Co Ltd

Hanmi Pharmaceutical Industries Co Ltd

Original Assignee

Hanmi Pharmaceutical Co Ltd

Hanmi Pharmaceutical Industries Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-08

Filing date

2004-10-07

Publication date

2007-04-04

2004-10-07 Application filed by Hanmi Pharmaceutical Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd

2006-10-18 Publication of EP1711490A1 publication Critical patent/EP1711490A1/de

2007-04-04 Publication of EP1711490A4 publication Critical patent/EP1711490A4/de

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP04774781A 2003-10-08 2004-10-07 Neuer p-glycoproteininhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält Withdrawn EP1711490A4 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR1020030069803A KR100580743B1 (ko)	2003-10-08	2003-10-08	다약제 내성 저해 활성을 갖는 신규한 크로몬 유도체 또는이의 약제학적으로 허용가능한 염 및 이들의 제조 방법
PCT/KR2004/002557 WO2005033101A1 (en)	2003-10-08	2004-10-07	Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the same

Publications (2)

Publication Number	Publication Date
EP1711490A1 EP1711490A1 (de)	2006-10-18
EP1711490A4 true EP1711490A4 (de)	2007-04-04

Family

ID=36968286

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP04774781A Withdrawn EP1711490A4 (de)	2003-10-08	2004-10-07	Neuer p-glycoproteininhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält

Country Status (3)

Country	Link
EP (1)	EP1711490A4 (de)
KR (1)	KR100580743B1 (de)
WO (1)	WO2005033101A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100557093B1 (ko)	2003-10-07	2006-03-03	한미약품 주식회사	다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법
KR100724125B1 (ko) *	2005-02-24	2007-06-04	한국과학기술연구원	칼페인 저해제로 유용한 크로몬 유도체 및 이의 제조방법
KR100880163B1 (ko) *	2007-05-30	2009-02-04	(주)바이오버드	신규한 다약제 내성 억제 화합물 및 이를 포함하는약제학적 조성물
JP2020526537A (ja)	2017-07-14	2020-08-31	ユニバーシティオブマサチューセッツ	炎症を処置するための方法および組成物
WO2020041378A1 (en)	2018-08-22	2020-02-27	Bacainn Therapeutics, Inc.	Cyclosporine compositions and methods of use
EP3893875A1 (de) *	2018-12-14	2021-10-20	Athenex HK Innovative Limited	Therapeutische kombinationen aus oral verabreichtem irinotecan und einem p-gp-hemmer zur behandlung von krebs
CN111732567B (zh) *	2020-06-17	2022-07-08	遵义医科大学	一种含色酮骨架类多环化合物、制备方法及其应用
US20220106301A1 (en) *	2020-10-07	2022-04-07	Athenex, Inc.	Acetamido-phenylbenzamide derivatives and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6011069A (en) *	1995-12-26	2000-01-04	Nisshin Flour Milling Co., Ltd.	Multidrug resistance inhibitors
GB9717576D0 (en) *	1997-08-19	1997-10-22	Xenova Ltd	Pharmaceutical compounds
US6693099B2 (en) *	2000-10-17	2004-02-17	The Procter & Gamble Company	Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
KR100503161B1 (ko) *	2002-07-18	2005-07-25	한미약품 주식회사	신규한 ｐ-당단백질 저해제, 그의 제조방법 및 이를유효성분으로 하는 경구투여용 조성물

2003
- 2003-10-08 KR KR1020030069803A patent/KR100580743B1/ko not_active IP Right Cessation
2004
- 2004-10-07 EP EP04774781A patent/EP1711490A4/de not_active Withdrawn
- 2004-10-07 WO PCT/KR2004/002557 patent/WO2005033101A1/en active Application Filing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number	Publication date
KR20050034024A (ko)	2005-04-14
WO2005033101A1 (en)	2005-04-14
EP1711490A1 (de)	2006-10-18
KR100580743B1 (ko)	2006-05-15

Similar Documents

Publication	Publication Date	Title
HK1167332A1 (en)	2012-11-30	Pharmaceutical composition, use thereof and method for making the same
IL165977A (en)	2010-12-30	Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
EP1603593A4 (de)	2007-08-01	Pharmazeutische zusammensetzung
IL175300A0 (en)	2006-09-05	Indirubin-type compounds, compositions, and methods for their use
IL174479A (en)	2015-08-31	The derivatives of myastrin, pharmaceutical preparations containing them and their uses
IL197889A (en)	2013-03-24	Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same
GB0300427D0 (en)	2003-02-05	Pharmaceutical composition
AU2003250372A8 (en)	2004-01-06	Pharmaceutical composition
GB0307866D0 (en)	2003-05-14	Pharmaceutical composition
EP1699458A4 (de)	2012-04-25	Pharmazeutische zusammensetzung
HK1090356A1 (en)	2006-12-22	2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
GB0329232D0 (en)	2004-01-21	Pharmaceutical composition
GB0317663D0 (en)	2003-09-03	Pharmaceutical composition
IL181216A0 (en)	2007-07-04	3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
EP1711490A4 (de)	2007-04-04	Neuer p-glycoproteininhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält
PL374761A1 (en)	2005-10-31	N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
EP1765373A4 (de)	2011-01-19	Ozonisierte pharmazeutische zusammensetzungen und verfahren
GB0306933D0 (en)	2003-04-30	Pharmaceutical composition
GB0307869D0 (en)	2003-05-14	Pharmaceutical composition
AU2003281533A1 (en)	2004-02-09	Novel p-glycoprotein inhibitor, method for preparing same and oral composition comprising same
EP1515960A4 (de)	2006-07-26	2-thioxothiazolderivat, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die dieses enthält
GB0307862D0 (en)	2003-05-14	Pharmaceutical composition
GB0307867D0 (en)	2003-05-14	Pharmaceutical composition
GB0307864D0 (en)	2003-05-14	Pharmaceutical composition
AU2003232684A8 (en)	2004-01-06	Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same

Legal Events

Date	Code	Title	Description
2006-09-15	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2006-10-18	17P	Request for examination filed	Effective date: 20060814
2006-10-18	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
2007-01-17	DAX	Request for extension of the european patent (deleted)
2007-04-04	A4	Supplementary search report drawn up and despatched	Effective date: 20070301
2007-05-11	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1093204 Country of ref document: HK
2009-09-18	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2010-07-16	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2010-08-18	18D	Application deemed to be withdrawn	Effective date: 20100212
2013-05-03	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1093204 Country of ref document: HK